Plasma Level of Adrenomedullin Is Influenced by a Single Nucleotide Polymorphism in the Adiponectin Gene

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wong, Hoi Kin ^a   Ong, Kwok Leung ^b   Leung, Raymond Y H ^a   Cheung, Tommy T ^a   Xu, Aimin ^a   Lam, Tai Hing ^a   Lam, Karen S L ^a   Cheung, Bernard M Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADRENOMEDULLIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADIPONECTIN GENE; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; ADRENOMEDULLIN; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84880990242     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070335     Document Type: Article

References (46)

1. Rosen ED, Spiegelman BM, (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444: 847-853.
2. Berg AH, Combs TP, Scherer PE, (2002) ACRP30/adiponectin: anadipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13: 84-89.
3. Kaser S, Tatarczyk T, Stadlmayr A, Ciardi C, Ress C, et al. (2008) Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur J Clin Incest 38: 827-834.
4. Li Y, Jiang C, Wang X, Zhang Y, Shibahara S, et al. (2007) Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues. Peptides 28: 1129-1143.
5. Cheung BM, Li CY, Wong LY, (2004) Adrenomedullin: its role in the cardiovascular system. Semin Vasc Med 4: 129-134.
6. Cheung B, Leung R, (1997) Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin Sci (Lond) 92: 59-62.
7. Cheung BM, Ong KL, Tso AW, Leung RY, Cherny SS, et al. (2011) Plasma adrenomedullin level is related to a single nucleotide polymorphism in the adrenomedullin gene. Eur J Endocrinol 165: 571-577.
8. Wong HK, Ong KL, Leung RY, Lam TH, Thomas GN, et al. (2012) A single nucleotide polymorphism of interleukin-6 gene is related to plasma adrenomedullinlevels. Clin Endocrinol (Oxf) 2012 Oct 22. doi: 10.1111/cen.12078 [Epub ahead of print].
9. Henneman P, Aulchenko YS, Frants RR, Zorkoltseva IV, Zillikens MC, et al. (2010) Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome-related traits. Diabetes Care 33: 908-913.
10. Hivert MF, Manning AK, McAteer JB, Florez JC, Dupuis J, et al. (2008) Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 57: 3353-3359.
11. Ong KL, Li M, Tso AW, Xu A, Cherny SS, et al. (2010) Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol 163: 251-257.
12. Lim SC, Morgenthaler NG, Subramaniam T, Wu YS, Goh SK, et al. (2007) The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes. Diabetes Care 30: 1513-1519.
13. Liao SB, Wong PF, O WS, Cheung BM, Tang F (2012) Effects of Adrenomedullin on Tumour Necrosis Factor Alpha, Interleukins, Endothelin-1, Leptin, and Adiponectin in the Epididymal Fat and Soleus Muscle of the Rat. Horm Metab Res Sep 6. [Epub ahead of print].
14. Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, et al. (2007) Development of diabetes in Chinese with the metabolic syndrome. Diabetes Care 30: 1430-1436.
15. Cheung BM, Wat NM, Man YB, Tam S, Cheng CH, et al. (2008) Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2). Am J Hypertens 21: 17-22.
16. Mok MY, Cheung BM, Lo Y, Leung RY, Wong WS, et al. (2007) Elevated plasma adrenomedullin and vascular manifestations in patients with systemic sclerosis. J Rheumatol 34: 2224-2229.
17. Cheung BM, Ong KL, Tso AW, Cherny SS, Sham PC, et al. (2011) Gamma-glutamyl transferase level predicts the development of hypertension in Hong Kong Chinese. Clin Chim Acta 412: 1326-1331.
18. Woo YC, Tso AW, Xu A, Law LS, Fong CH, et al. (2012) Combined use of serum adiponectin and tumor necrosis factor-alpha receptor 2 levels was comparable to 2-hour post-load glucose in diabetes prediction. PloS One 7: e36868.
19. Alberti KG, Zimmet P, (1998) diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 15: 539-553.
20. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792.
21. Finelli C, Tarantino G, (2013) What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J Gastroenterol 19: 802-812.
22. Tsukinoki R, Morimoto K, Nakayama K, (2005) Association between lifestyle factors and plasma adiponectin levels in Japanese men. Lipids Health Dis 4: 27.
23. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
24. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, et al. (1994) Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 94: 2158-2161.
25. Yu C, Cheung BMY, Leung R, Wang Q, Lai W, et al. (2001) Increase in plasma adrenomedullin in patients with heart failure characterised by diastolic dysfunction. Heart 86: 155-160.
26. Bunton DC, Petrie MC, Hillier C, Johnston F, McMurray JJV, (2004) The clinical relevance of adrenomedullin: a promising profile? Pharmacol Ther 103: 179-201.
27. Potocki M, Ziller R, Mueller C, (2012) Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker? Curr Heart Fail Rep 9: 244-251.
28. Nishida H, Horio T, Suzuki Y, Iwashima Y, Kamide K, et al. (2008) Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin. Peptides 29: 599-605.
29. Torigoe M, Matsui H, Ogawa Y, Murakami H, Murakami R, et al. (2007) Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men. Clin Endocrinol (Oxf) 67: 276-281.
30. Hashimoto N, Kanda J, Nakamura T, Horie A, Kurosawa H, et al. (2006) Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism 55: 1653-1657.
31. Hui X, Lam KS, Vanhoutte PM, Xu A, (2012) Adiponectin and cardiovascular health: an update. Br J Pharmacol 165: 574-590.
32. Xu A, Vanhoutte PM, (2012) Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol 302: H1231-1240.
33. Goldstein BJ, Scalia RG, Ma XL, (2009) Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med 6: 27-35.
34. Henneman P, Aulchenko YS, Frants RR, Zorkoltseva IV, Zillikens MC, et al. (2010) Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome-related traits. Diabetes Care 33: 908-913.
35. Hivert MF, Manning AK, McAteer JB, Florez JC, Dupuis J, et al. (2008) Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 57: 3353-3359.
36. Tso AW, Sham PC, Wat NM, Xu A, Cheung BM, et al. (2006) Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study. Diabetologia 49: 1806-1815.
37. Darlington GJ, Ross SE, MacDougald OA, (1998) The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273: 30057-30060.
38. Iemura-Inaba C, Nishikimi T, Akimoto K, Yoshihara F, Minamino N, et al. (2008) Role of adrenomedullin system in lipid metabolism and its signaling mechanism in cultured adipocytes. Am J Physiol Regul Integr Comp Physiol 295: R1376-1384.
39. Cheung BM, Hwang IS, Li CY, O WS, Tsang KW, et al. (2004) Increased adrenomedullin expression in lungs in endotoxaemia. J Endocrinol 181: 339-345.
40. Wong LYF, Cheung BMY, Li Y, Tang F, (2005) Adrenomedullin Is Both Proinflammatory and Antiinflammatory: Its Effects on Gene Expression and Secretion of Cytokines and Macrophage Migration Inhibitory Factor in NR8383 Macrophage Cell Line. Endocrinology 146: 1321-1327.
41. Cheng KY, Lam KS, Wang Y, Xu A, (2006) Adiponectin as a key player in inflammation. Biomedical Review 17: 11-22.
42. Fantuzzi G, (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115: 911-919.
43. Zhu W, Cheng K, Lam KS, Xu A, (2008) Vascular actions of adiponectin: Molecular Mechanisms and Therapeutic intervention. Clin Science, (Lond) 114: 361-374.
44. Sanghera DK, Demirci FY, Been L, Ortega L, Ralhan S, et al. (2010) PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor. Metabolism 59: 492-501.
45. Vasseur F, Caeyseele T, Barat-Houari M, Lobbens S, Meirhaeghe A, et al. (2010) Concordance of two multiple analytical approaches demonstrate that interaction between BMI and ADIPOQ haplotypes is a determinant of LDL cholesterol in a general French population. J Hum Genet 55: 227-231.
46. Cromwell WC, Otvos JD, (2004) Low-density lipoprotein particle number and risk for cardiovascular disease. Curr Atheroscler Rep 6: 381-387.